This site is intended for healthcare professionals
Guidelines
  • Home
  • /
  • Guidelines
  • /
  • Hidradenitis suppurativa
  • /
  • Swiss S1 guidelines for the management of hidraden...
Guideline

Swiss S1 guidelines for the management of hidradenitis suppurativa

Read time: 1 mins
Last updated: 19th Feb 2026
Availability: Pay for access, or by subscription
Status: Current
Swiss S1 guidelines for the management of hidradenitis suppurativa - Swiss Hidradenitis Suppurativa Foundation


Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition characterized by painful nodules, abscesses, and sinus tracts, causing significant physical and psychological distress. The profound impact of HS underscores the need for comprehensive management strategies to enhance patient outcomes and quality of life. This S1 guideline, developed by the Swiss HS Foundation, provides evidence-based recommendations for systemic and surgical treatments in HS, emphasizing the importance of standardized care practices. It incorporates insights and an informal expert consensus of Swiss dermatologists and dermatosurgeons. The guideline addresses conventional therapies, such as antibiotics and retinoids, as well as emerging biological treatments and surgical interventions, offering a holistic approach to managing this challenging disease.


Read full Guideline